Cancer
-
Gender response to chemotherapy investigated
Women given chemotherapy for oesophagogastric cancer had better survival than men – but experienced worse side effects, a UK-based research project has found. Read more
-
Warning on growing palliative care needs
The number of people needing palliative care globally is set to double in the next 40 years, according to a new projection. Read more
-
New gene test for bowel cancer subtype
A test has been unveiled that enables clinicians making a diagnosis of bowel cancer to identify which of five sub-types is involved. Read more
-
Cancer diagnosis risk for women with sleep apnoea
Women with obstructive sleep apnoea are more likely to be diagnosed with cancer than men with the condition, according to Greek research published last night. Read more
-
Europe sees bowel cancer rise in young adults
The rate of bowel cancer is rising among adults in Europe, researchers report today. Read more
-
Liquid biopsy could help to halt metastatic cancer
A liquid biopsy could help to identify cancer patients who are at risk of their disease spreading, a conference heard yesterday (15 May 2019). Read more
-
World’s first ‘Darwinian’ cancer drug programme announced
The world’s first ‘Darwinian’ drug discovery programme, designed to tackle cancer’s ability to evolve resistance to treatment, is to be launched in the UK, it is announced today. Read more
-
Backing for radiotherapy side-effect gel
Hospitals are to be encouraged to use an injectable gel to reduce the side-effects of prostate cancer radiotherapy, it has been announced. Read more
-
Retinoblastoma gene points to prostate problems
A gene linked to eye cancer may also indicate a man’s risk of developing aggressive forms of prostate cancer, British researchers reported last night. Read more
-
Metastatic cells "opportunistic" – new analysis
British researchers have offered a radical new view of how cancers metastasise by getting into the vascular and lymphatic systems. Read more
